Ten-year survival rates in breast cancer using combination chemotherapy.
The outcome in 254 patients with all stages of breast cancer treated by combination chemotherapy is presented. All the patients were treated 10 or more years ago. The 10-year survival rate for Stages I and II combined is 60 per cent, in Stage III 19 per cent and in Stage IV 3 per cent. The combined rate in Stages I and II differed markedly according to hormonal status. In premenopausal patients the rate was 84 per cent compared with 42 per cent in postmenopausal patients.
D000328:Adult; D000368:Aged; D000728:Androgens / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000401:mortality* / Q000601:surgery; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008408:Mastectomy; D008875:Middle Aged; D013852:Thiotepa / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D000728:Androgens; D013852:Thiotepa